The ProShares S&P 500 Ex-Technology ETF (SPXT) aims to reduce the heavy concentration of IT stocks in the S&P 500 but struggles to outperform the broader market. SPXT cannot completely avoid tech-like exposures, and excluding IT sector stocks limits its potential gains, negatively impacting both cumulative and risk-adjusted returns. Its portfolio leans more towards value and low volatility stocks compared to the iShares Core S&P 500 ETF (IVV), but it falls short on growth-at-a-reasonable-price (GARP) metrics, which is a key weakness. Due to this factor composition, SPXT is unlikely to outperform IVV in the current year.
As of August 11, 2026, Tron (TRX) trades around $0.3347, positioned in the middle of its 12-month range between a low of $0.2692 and a high of $0.3753. The price shows little momentum and moves sideways near its 50- and 200-day moving averages, indic...
Analyst Barrington raised ICF International's price target to $110, suggesting a 24.45% upside from $88.39. The company expects 3% revenue growth and 5% non-GAAP EPS growth in 2026, fueled by energy, AI, and federal modernization efforts. Q2 2026 ear...
HSBC has upgraded YPF's rating to Buy following strong Q2 2026 results, including a 41.7% revenue increase to $6.57 billion and earnings per share of $3.07, surpassing estimates. YPF raised its 2026 adjusted EBITDA guidance to $8 billion and aims for...
Vivos Therapeutics reported Q2 2026 earnings per share of -$0.31, beating analyst expectations of -$0.42, but its revenue of $5.15 million fell short of the $5.63 million estimate. The company, focused on sleep apnea treatments, sees growing patient ...
Ether.fi's protocol activity is growing, evidenced by rising fees reaching $2.8 million weekly and total value locked (TVL) increasing to $3.532 billion. The number of token holders has also grown to 131,940, indicating sustained demand despite no bu...
